3217 First-line chemotherapy treatment in the management of mantle cell lymphoma: A systematic review von Stradwick, S, Gairy, K, Seshagiri, D

Volltext

PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK: A Cost-Utility Analysis von Taylor, M, Serbetci, E, Ferreira, A, Gairy, K, Blouin, J, Mitchell, P, Lewis, L

Volltext

EE618 Healthcare Resource Utilisation and Economic Burden Associated With Lupus Nephritis in China: A National Claims Database Study von Zhu, X, Han, S, He, X, Tang, Z, Gairy, K, Juliao, PC, Wu, Z

Volltext

PSY10 PRIMARY SJOGREN'S SYNDROME: A RETROSPECTIVE COHORT STUDY OF BURDEN OF ILLNESS IN SWEDEN von Westerlund, A., Beydogan, H., Kejs, A.M., Gairy, K.

Volltext

PCN131 - Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma not Eligible for Stem Cell T... von Van Keep, MM, Gairy, K, Seshagiri, D, Thilakarathne, P, Lee, D

Volltext

Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma not Eligible for Stem Cell Transplant... von Van Keep, MM, Gairy, K, Seshagiri, D, Thilakarathne, P, Lee, D

Volltext

PHP31 EUROPEAN PRICING AND REIMBURSEMENT UPDATE: OPTIMAL MONETARY BENEFITS CAN DEPEND ON WHICH COUNTRYTHE PROCESS IS INITIATED von Perard, R, Gairy, K, Gani, R

Volltext